Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis
- 1 April 1998
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Biotechnology
- Vol. 16 (4), 359-363
- https://doi.org/10.1038/nbt0498-359
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer familiesNature Medicine, 1996
- The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosisJAMA, 1996
- Improved Outcomes for Patients with Multidrug-Resistant TuberculosisClinical Infectious Diseases, 1995
- Characterization of rifampin-resistance in pathogenic mycobacteriaAntimicrobial Agents and Chemotherapy, 1994
- Transmission of Tuberculosis in New York City -- An Analysis by DNA Fingerprinting and Conventional Epidemiologic MethodsThe New England Journal of Medicine, 1994
- Detection of rifampicin-resistance mutations in Mycobacterium tuberculosisThe Lancet, 1993
- Treatment of 171 Patients with Pulmonary Tuberculosis Resistant to Isoniazid and RifampinThe New England Journal of Medicine, 1993
- The Use of Molecular Methods in Infectious DiseasesThe New England Journal of Medicine, 1992
- An Outbreak of Tuberculosis Caused by Multiple-Drug-resistant Tubercle Bacilli among Patients with HIV InfectionAnnals of Internal Medicine, 1992
- The Polymerase Chain ReactionThe New England Journal of Medicine, 1990